Troy Madsen, MD
Emergency Medicine · Salt Lake City, UTNPI 1689609240
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Mimedx Group, Inc. at 42.0% of the total.
Across 7 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$50
- Integra Lifesciences Corporation$31
- Organogenesis Inc.$22
- Solventum Corporation$17
Across 1 payment — averaging $150,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- BD$150K
What the payments were for
- Food & beverage$120100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mimedx Group, Inc. | 3 | $50 |
| Integra Lifesciences Corporation | 2 | $31 |
| Organogenesis Inc. | 1 | $22 |
| Solventum Corporation | 1 | $17 |
How this compares
$120 in reported general payments places this provider in the 80th percentile of 410 emergency medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 34 | $447 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $285 |
| Cephalexin | 14 | $119 |
| Amoxicillin | 17 | $63 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Salt Lake City
- Christian NeffSalt Lake City$66K
- Patrick OckerseSalt Lake City$61K
- Joseph BledsoeSalt Lake City$34K
- Jackson RhudySalt Lake City$8K
- Luisa ToddSalt Lake City$6K
- Pamela FarmerSalt Lake City$5K
- Franziska GarrettSalt Lake City$4K
- Deanne LongSalt Lake City$2K
- Joseph TonnaSalt Lake City$1K
- Christopher KellySalt Lake City$582
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.